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Abbreviations 
CRS: Congenital Rubella Syndrome 
CRI: Congenital Rubella Infection 
EPI: Expanded Program on Immunization 
PCR: Polymerase Chain Reaction 
LBW: Low birth-weight 
SGA: Small for gestational age 
Prematurity: infants born before 37 completed weeks 
PDA: Patent ductus arteriosus 
PPS: Peripheral pulmonary stenosis 
VSD: Ventricular septal defect 
CDC: Centers for Disease Control 
WHO: World Health Organization 
MMR: Measles mumps rubella 
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NHLS: National Health Laboratory Services 
ICU: Intensive Care Unit 
ABSTRACT 
Background: Congenital rubella syndrome (CRS) is characterized by multiple 
defects causing physical, intellectual and developmental retardation, auditory 
and visual problems, placing a huge burden on health care services in countries 
where rubella immunization is not routine. The incidence and extent of CRS in 
South Africa, where rubella vaccine is not included in the expanded program on 
immunization (EPI), is unknown. 
 
Objective: To determine the minimum prevalence and morbidity of CRS in the 
public sector of the Western Cape province of South Africa, as well as to describe 
the clinical presentation and features of all confirmed and probable CRS cases at 
Tygerberg Children’s Hospital. 
 
Methods: A retrospective descriptive study and case series using clinical records. 
Rubella serology data was retrieved from National Health Laboratory Systems at 
Tygerberg Academic Hospital between 01 January 2006 and 31 December 2011 
and Groote Schuur Hospital between 01 January 2008 and 31 December 2011. 
For confirmed CRS, detection of rubella by PCR or specific IgM antibodies below 3 
months of age was diagnostic. For probable CRS, a PCR or IgM positive at 3 
months - 1 year of age with more than two of the following conditions: cataracts, 
congenital glaucoma, congenital heart disease, hearing impairment or 
pigmentary retinopathy. Alternatively, one of one of these conditions plus any of 
the following: purpura, splenomegaly, microcephaly, mental retardation, 
meningoencephalitis, radiolucent bone disease or neonatal jaundice within 24 
hours of birth. 
 
Confirmed cases between 01 January 2008 and 31 December 2011 from the two 
laboratories were used to calculate a minimum prevalence for the Western Cape. 
Medical records of infants with confirmed and probable CRS under a year of age 
from Tygerberg between 01 January 2006 and 31 December 2011 were reviewed 
for inclusion in the case series. 
 
Results: Thirty confirmed cases were identified from 01 January 2008 and 31 
December 2011 in the two laboratories for a minimum prevalence of 0.073 cases 
per 1000 population for the Western Cape (95% confidence interval [CI] 0 – 0.1). 
Twenty confirmed and probable cases were obtained from Tygerberg Children’s 
Hospital from 01 January 2006 to 31 December 2011. The median gestational age 
at birth was 37 weeks (interquartile range [IQR] 32 – 38). Fourteen (70%) had 
low birth weight (LBW), nine (45%) were premature and seven (35%) were 
small for gestational age (SGA). Six women (30%) gave a history of rubella in 
pregnancy, five in the first trimester and one in the second trimester. The most 
common presenting signs were: petechiae in eight (40%), and cataracts in seven 
(35%) infants. Other presenting signs in the infants included 
hepatosplenomegaly. Nine (45%) had ophthalmologic involvement, all with 
cataracts; of these three had pigmentary retinopathy and one had congenital 
glaucoma. Four of the twelve tested (33%) had hearing impairment and ten 
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(50%) had microcephaly. Cardiac anomalies were noted in eleven of the infants. 
One infant presented with bilateral knee arthritis, not previously described in 
CRS. 
 
Eleven of fourteen LBW infants (79%) and three of six (50%) with birth weights 
above 2500g had at least one major congenital anomaly (p = 0.3). All three deaths 
occurred in SGA term infants. Eight of the twenty infants (40%) required more 
than one hospital admission, with seven (35%) also requiring intensive care. 
Hospital stay in LBW infants was also significantly longer than those with birth 
weights above 2500g (median 27 vs 6 days) (p = 0.01). Seven patients (35%) 
underwent a surgical procedure with three requiring more than one procedure. 
PDA ligation and cataract removal were most common. 
 
Conclusions: CRS has extensive morbidity and high mortality, requiring a 
multidisciplinary approach. Rubella immunization should be urgently 
incorporated into the extended program of immunization in South Africa to 
prevent this devastating infection. 
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Introduction 
Rubella occurs mainly in children and young adults, usually without serious 
sequelae. However, infection in pregnancy, especially during the first 18 weeks is 
teratogenic as first described in 1941 by Sir Norman McAlister Gregg, an 
Australian ophthalmologist [1]. Swan et al expanded this initial description and 
described low birth weight (LBW), congenital heart disease, cataracts, deafness 
and central nervous system (CNS) damage as part of the congenital rubella 
syndrome (CRS). Prior to developing an effective vaccine in 1969, rubella 
outbreaks occurred episodically. The most recent major pandemic occurred 
between 1963 and 1965, affecting 10% of pregnant women with thousands of 
fetal and early neonatal deaths and severe congenital defects [2]. 
 
Pathogenesis 
Rubella is a single-stranded RNA virus of the genus Rubivirus with one serotype. 
Infection is spread through droplets. Prior to a maternal immune response, 
rubella virus infects the placenta and spreads hematogenously to the fetus. The 
fetus relies on maternal IgG to overcome the infection. Placental transfer is 
inefficient early in pregnancy when the virus is most fetotoxic. Maturation of the 
placenta, increased transfer of maternal antibodies as well as development of the 
fetal immune response limit viral activity in the second trimester, with fetal 
damage rare after this time. Organogenesis appears largely unaffected with 
damage occurring in established structures such as the eye and inner ear. Rubella 
causes necrosis in cardiac endothelium, resulting in patent ductus arteriosus 
(PDA), peripheral pulmonary stenosis (PPS) and ventricular (and atrial septal 
defects (VSD). Vascular insufficiency may result in growth retardation, deafness 
and neurodegenerative damage [2]. 
 
Definitions 
The Centers for Disease Control (CDC) definition of congenital rubella infection 
(CRI) includes all outcomes associated with intrauterine rubella infection. These 
include miscarriage, stillbirth, abortion, combinations of birth defects and 
asymptomatic infection. 
CRS refers to variable constellations of birth defects. The highest risk of CRS and 
CRI is in countries with high susceptibility rates among women of childbearing 
age due to inadequate pre-conceptual vaccination. The risk of CRI varies 
according to the time of onset of maternal infection during pregnancy, with the 
highest risk in the first trimester (80 – 100%), 50% in the 13th and 14th weeks, 
12% in weeks 24 – 28, 19% after rubella during weeks 28 – 36 and then 
increases again to 58% when the illness occurs in the last month of pregnancy 
[3,4,5]. Embryopathy is not invariable after intrauterine infection. The risk for 
malformations is 90% in the first 11 weeks of pregnancy, 33% in weeks 11-12, 
11% in weeks 13-14 and 24% in weeks 15-16 [6]. No malformations were noted 
in those infected after week 18 [2]. (Figure 1) 
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Figure 1: Risk of CRI [5] and CRS [2,6] 
 
 
CRS comprises a combination of defects, particularly the heart (PDA, PPS or VSD), 
craniofacial (microcephaly), eyes (cataracts, microphthalmia, glaucoma, 
chorioretinitis) and ears (sensorineural deafness). Neonatal manifestations of 
CRI include hepatosplenomegaly, meningoencephalitis, hepatitis, 
thrombocytopenia and long bone radiolucency. The later sequelae of CRI include 
thyroiditis, diabetes mellitus and autism, which may not be recognized initially 
[7]. CRS places a huge burden on health services in countries where rubella 
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Congenital defects Late manifestations 
Ophthalmic defects 
       Cataracts 
       Chorioretinitis 
       Glaucoma 
       Microphthalmia 
Diabetes mellitus type 1 
Thyroiditis 
Growth hormone deficit 
Autism spectrum disorder 
Pan-encephalitis (rare) 
Audiologic defects 
       Sensorineural deafness 
Cardiac defects 
       Patent ductus arteriosus 
       Peripheral pulmonary stenosis 
       Ventricular septal defect 
Central nervous system 
       Microcephaly 
       Meningoencephalitis 
Other 
       Intrauterine growth restriction 
       Thrombocytopenia 
       Hepatosplenomegaly 
       Radiolucent bone disease 
       Prolonged jaundice 
Table 1: Early and late manifestations of CRS [7] 
 
 
Diagnosis and case definitions of congenital rubella infection 
Pregnancy [8] 
Early diagnosis of acute rubella infection in pregnancy is imperative. Clinical 
diagnosis is unreliable as infection is often subclinical with non-specific 
symptoms. 
The diagnosis of acute rubella infection is made by any of the following:  
 Four-fold rise in rubella IgG antibody titer between acute and 
convalescent serum specimens 
 Positive rubella-specific IgM antibody 
 Positive rubella culture (on nasal, blood, urine or cerebrospinal fluid) 
Antenatal rubella screening is seldom done in all countries due to its cost.  
 
Infant 
Antibody in the fetus may be transplacentally acquired, produced by the fetus or 
both. Passively acquired maternal antibody is found up to 15 months after 
delivery and is entirely IgG. In contrast, the antibodies produced by the infant 
may comprise of IgG (indistinguishable from the transplacentally acquired IgG) 
and IgM. Thus IgM is used diagnostically [9]. 
 
The detection of rubella specific IgM using a -capture ELISA in cord blood or 
infant serum is the method of choice. However, false negative rubella IgM results 
can occur [10]. Specific IgM has been demonstrated in all confirmed cases up to 3 
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months of age, in 86% between 3 and 6 months, 62% between 6 and 12 months 
and in 42% between 12 and 18 months [11]. Since rubella is uncommon below the 
age of 2 years due to the passively acquired maternal IgG, IgM detected below a 
year likely indicates CRI [11]. Reverse transcriptase polymerase chain reaction 
assays (PCR) can also be used to detect rubella virus after growth in tissue 
culture or directly from clinical specimens.  Appropriate specimens include nasal 
and throat swabs, cerebrospinal fluid, cataracts, blood and urine. 
 
 
Epidemiology of congenital rubella infection  
The global incidence of CRS is estimated between 0.1 and 0.2/1000 live births in 
endemic periods and up to 1 – 4/1000 live births following epidemics [12]. 
Reliable statistics are unavailable for many developing countries, but the 
estimated worldwide caseload exceeds 100 000 cases [13]. However, in 1995 only 
37 cases were reported to the World Health Organization (WHO) with none from 
South Africa. Many remain undiagnosed, as clinical manifestations may not be 
apparent at birth. Some manifestations of CRS, such as auditory impairment and 
developmental retardation become apparent later in childhood and may then be 
difficult to ascribe to CRS. (Table 1) 
In South Africa, an incidence of 0.06 cases of acute rubella per 1000 population 
can be extrapolated from the case-based measles surveillance program initiated 
by the South African National Institute for Communicable Diseases in 1998. From 
1 January 2011 to 31 December 2011 38% of suspected measles cases (3268 
cases) were rubella IgM positive, females accounting for 49%, of whom 12% 
were in women of childbearing age [14]. The estimated population in 2011 used as 
the denominator was 51,770,560. 
 
As CRS is neither notifiable nor monitored, its incidence in South Africa is 
unknown. Schoub et al estimated 654 CRS cases in South Africa annually, 
translated into 0.5/1000 live births – above the WHO estimate of 0.1 – 0.2 / 1000 
in endemic periods [12]. Corcoran and Hardie documented that 4.7% of women of 
childbearing age were susceptible to rubella in the Western Cape. Also, immunity 
was higher in the age group of 35-45 years than 15 – 24 years, suggesting that 
primary infection occurs also in the childbearing age [15]. The serological 
immunity gap defined as the number of women susceptible to rubella differs in 
the private and public sectors in South Africa, estimated as 10% and 5% 
respectively. [12]. Although better living conditions and less crowding are largely 
responsible for decreased immunity in the upper socio-economic group, a low 
uptake (59%) of the Measles Mumps Rubella (MMR) vaccine is contributory [12]. 
Such partial coverage causes a paradoxical increase in young females susceptible 
to wild-type virus in their childbearing years. This scenario was documented in 
Greece in the 1990’s [16].  
 
Rubella vaccine based on the live, attenuated RA27/3 strain is safe and effective 
and available either as a single component, combined with measles vaccine (MR) 
or MMR. Seroconversion after vaccination exceeds 95%. Vaccine-induced 
immunity is assumed to be life-long.  Since its use from the early 1970s, the 
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incidence of CRS in the developed world has dramatically declined. For example, 
in the United States of America (USA) between 1962 and 1965 about 20 000 
newborns had CRS, but after vaccine licensure in 1969, CRS decreased 
dramatically, with only 18 cases reported in 2002 [13]. By 1997, 78 countries 
(92% industrialized, 36% in economic transition and only 28% of developing 
countries) included rubella vaccine in their national immunization programs. 
In 1999 Cutts and Vynnycky modeled rubella serosurvey data to estimate the 
number of new CRS cases for 1996 in developing countries as follows (See Table 
2): [17]  
 
WHO REGION NEW CASES 
South East Asia 46 621 
Africa 22 471 
Americas 15 994 
Western Pacific 12 634 
Eastern Mediterranean 12 080 
Table 2: Estimate of new CRS cases in developing countries for 1996  
  





The aims of this study were to 1) establish a minimum prevalence of confirmed 
CRI in the Western Cape public sector and to 2) describe the clinical presentation 




This was a retrospective descriptive study and case series using laboratory and 
clinical records. 
Laboratory identification of CRS 
Rubella serology and PCR data were retrieved from National Health Laboratory 
Systems (NHLS) virology databases at Tygerberg Academic and Groote Schuur 
Hospitals between 1 January 2006 and 31 December 2011. Data from GSH were 
unavailable prior to 2008 and therefore only cases from 1 January 2008 to 31 
December 2011 from GSH were identified. Both laboratories use the same 
diagnostic assays and quality assurance programs.  
We applied the following case definitions: 
 Confirmed case: Rubella PCR or IgM positive below 3 months of age 
 Probable case: an infant 3 months to 1 year of age with positive rubella 
PCR or IgM and at least 2 of the following features from  
- A: cataracts, congenital glaucoma, congenital heart disease, hearing 
impairment, pigmentary retinopathy OR one feature from A and one or 
more from  
- B: purpura, splenomegaly, microcephaly, mental retardation, meningo-
encephalitis, radiolucent bone disease or jaundice with onset within 
24hr of birth with no alternative etiology 
 
Population study 
All confirmed cases from the two NHLS laboratories between January 1, 2008 
and December 31, 2011 were used to calculate a minimum prevalence for the 
Western Cape. We obtained data for registered births in the Western Cape from 
the Department of Health. The estimated birth population (408252) was the 
number of registered births in the Western Cape from 2008 – 2011. 
Case series 
We reviewed the files of all children younger than 12 months with positive 
rubella IgM or PCR from Tygerberg Academic Hospital between 01 January 2006 
and 31 December 2011 to determine whether the children met the case 
definition for a confirmed or a probable case using the above definitions. Only 
probable and confirmed cases from Tygerberg Academic Hospital were included 
in our case series. 
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Statistics 
Data was collected in Excel and analyzed using Statistica (version 12 of 2014) 
and SAS version 9.1.3. Incidence/prevalence was presented using proportions 
with corresponding exact 95% confidence intervals (CI). Non-parametric 
methods were used for comparisons between groups. 
 
The minimum prevalence was calculated by taking the cases of CRS with the total 




Ethics approval was obtained from the Health Research Ethics Committee of 
Stellenbosch University (reference number S13/02/033). The Tygerberg 





Thirty confirmed cases of CRI were identified between 01 January 2008 and 31 
December 2011 – sixteen from Tygerberg and fourteen from Groote Schuur NHLS 
databases. No data were available for the preceding 2 years from Groote Schuur.  
The minimum prevalence for CRS was 0.073 cases per 1000 live births for the 
Western Cape (95% CI 0-0.1). The diagnosis was made by PCR in twelve cases 
and by IgM in eighteen. 
Case series 
Twenty confirmed and probable cases were obtained from Tygerberg Children’s 
Hospital from 01 January 2006 to 31 December 2011 for the case series. Patients 
from Groote Schuur database were excluded due to the inability to access 
medical records from affiliated hospitals. 
Diagnosis-: 
The diagnosis was made by PCR in four cases and by positive IgM in sixteen 
infants. In sixteen infants (80%) the diagnosis was in the first 3 months of life. 
 
Gender -:  
There was no significant difference in the gender with nine (45%) infants being 
female and eleven (55%) male.  
 
Race -:  
Fourteen (70%) infants were of mixed race, with one (5%) Caucasian and five 
(25%) Black infants.  
Birth data -:  
The median gestational age was 37 weeks (IQR 32 – 38) with nine babies being 
premature, and the median birth weight was 2040 grams (IQR 1550 – 2800). 
Fourteen (70%) were low birth weight of which five (35%) were term infants. Six 
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(30%) of all the infants were small for gestational age. Eleven of the fourteen 
LBW infants (80%) had at least one major congenital anomaly. These included 
ophthalmological disease, cardiac defects and hearing impairment. Major 




Figure 2: Birth data 
 
Clinical features:  
The most common presenting sign was purpura in thirteen (65%), followed 
closely by cataracts in seven (35%). Hepatosplenomegaly was the presenting sign 
in four (20%) infants.  Nine infants (45%) had eye involvement. All had cataracts, 
three also had pigmentary retinopathy and one had congenital glaucoma. 
Cataracts were never an isolated finding. Four (33,3%) of twelve patients tested 
had hearing impairment. Seventeen (85%) had hepatomegaly and ten (50%) had 
splenomegaly. Ten (50%) had microcephaly. Eleven (55%) had cardiac 
anomalies – nine (45%) with a PDA, of whom five also had PPS, one a VSD and 
another had total anomalous pulmonary venous drainage (TAPVD). The 
remaining two patients with cardiac anomalies had PPS (1 also had a VSD). 





















Weight <2500g Weight >2500g Gestational age
Premature
Term
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Figure 3: Clinical features of CRS  
CVS – cardiology, CNS – central nervous system, PDA – patent ductus arteriosus, 
PPS – peripheral pulmonary stenosis, ENNJ – early neonatal jaundice 
 
One infant presented with bilateral knee arthritis. (Not previously described in 
CRS – see case report on page 12).  
 
Hospitalization:  
8 (40%) patients had more than one hospital admission. Three (15%) were 
admitted twice and 5 patients (25%) had three or more admissions. 
Duration of hospitalization in LBW infants [median 27 (IQR 9 – 49) days] was 
significantly longer than those with birth weights above 2500g [median 6 (IQR 6 
– 11) days (p = 0.01). 7 (35%) infants including 4 premature infants, required 
intensive care admission. Seven patients (35%) underwent a surgical procedure 
with 3 requiring more than 1 procedure. PDA ligation and cataract surgery were 
most common. 
 
Follow-up and outcomes:  
The median follow up period was 25,9 (IQR 1 – 40) months. 14 (70%) of infants 
were referred to cardiology and 13 (65%) to ophthalmology services. 9 (45%) 
required more than one appointment for cardiology and 9 (45%) for 
ophthalmologists. Only 12 (60%) infants, of whom 4 (33%) had hearing 
impairment, were seen by the audiology service. (Figure 4) Of these, 10 (83%) 
required at least one follow-up appointment. Three deaths were recorded by two 
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Figure 4: Referrals and follow-up by special services  
 
 
Maternal information -: Due to the retrospective study design, maternal 
information was largely incomplete. 16 had antenatal care documented but more 
than two thirds were unaware of their rubella immune status. Of 6 (30%) with a 
history of rubella in pregnancy, 5 (83%) occurred in the first trimester and 1 case 
in the second trimester. 
 
 
CASE REPORT – RUBELLA PERI-ARTHROPATHY (Tenosynovitis?) 
This infant presented at 4 months of age with painful knees for 4 days with 
decreased movement and fever. Both knees were warm, tender and swollen. An 
effusion was noted in the right knee. Other manifestations of CRS included 
bilateral cataracts, PDA, hepatosplenomegaly and microcephaly. The mother had 
reported rubella-like illness in her pregnancy.  
Inflammatory markers were raised: the erythrocyte sedimentation rate was 130 
mm/hr (Normal: 0-10 mm/hr). C-reactive protein was 20 mg/l (Normal: 0-10 
mg/l), the white cell count was 14 x 109 (5.5-18.0 x 109) cells/L and neutrophil 
percentage was 22%, both within normal range.  
At arthrotomy done shortly after presentation, no effusion was found. Cultures 
on synovial biopsies were all negative. PCR for rubella on synovial fluid was also 
negative. On histology, no inflammation or atypia was seen. Serum IgM for 
rubella was positive. The infant was treated empirically with antibiotics and 6 




Our calculated CRS prevalence for the Western Cape is far lower than estimates 
of both Corcoran et al and WHO. Reasons include under-reporting and lack of 
awareness. The clinical manifestations may not be immediately apparent, but 
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Limitations in our calculation include uncertainty of the population of the 
Western Cape. The estimated population was calculated using the number of 
registered births in the Western Cape for 2008 to 2011 according to the Western 
Cape Department of Health. This however excludes late registrations and 
immigrants from other provinces that use the maternity services of the Western 
Cape health system and the private sector. 
 
We have documented CRS-related morbidity and mortality in TBH. Patients from 
hospitals other than TBH were not included in the case series due to the inability 
to access these patients’ files. The racial demographics of the patients reflect the 
population attending the public hospitals in the Western Cape. As previously 
noted [1,18], low birth weight due to prematurity and intrauterine growth 
restriction was documented in the majority of our case series. The mortality and 
morbidity was significantly higher in the low birth weight infants, with increased 
congenital anomalies and all deaths occurring in this group. Hospital stay in the 
LBW infants was also significantly longer – 35 days in LBW vs 9 days in infants 
above 2500g – resulting in increased cost and burden on the health care system. 
 
Petechiae and cataracts were the most common findings with cataracts present 
in almost half the patients. Both are detectable early and should raise suspicion 
and prompt early investigation of CRS. In our study, cataracts were significantly 
associated with cardiac disease (p = 0.008). Also, 77% of those with cataracts 
also had hearing impairment. Eckstein et al, in a study from India, found that 
cataract of nuclear morphology had a 75% positive predictive value for CRS and 
accounted for 25% of congenital cataracts in their survey [19]. There is wide 
variability in the incidence of pigmentary retinopathy, reported in 13 – 61% of 
case series [2] and noted in 15% of our cohort.  Multisystem involvement 
emphasizes the importance of proper screening in infants presenting with 
cataracts. The cardiac defects noted in our study correlated well with previous 
reports – just over half of the patients having a cardiac anomaly, most commonly, 
PDA. 
 
Only one third of those tested had hearing impairment. This may suggest a lower 
rate of hearing impairment than in other reports, where it is the most common 
congenital defect. Also, many patients in the study did not have a hearing 
assessment as they were born in outlying hospitals. Reasons include limited 
access to equipment and specialist services for newborn infants, available only at 
tertiary centers. Lack of awareness by inexperienced medical staff may 
contribute to inadequate referral and parents may not appreciate this risk. 
Hearing impairment may occur as a single defect, and may therefore not be 
actively sought [20]. Hearing impairment does not appear to be progressive [21] 
but early intervention is essential to preserve language development.  
 
Arthralgia is a recognized complication of acute rubella, occurring predominantly 
in adult females. We documented arthritis or tenosynovitis most likely as a new 
manifestation of CRS. Ogra et al hypothesized that arthritis following rubella 
vaccination was due to continued replication of the rubella virus in the affected 
joint, despite viral isolation from the joint being rare. Other investigators have 
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been unable to prove this, suggesting that the pathogenesis of post vaccination 
arthritis was due to an immunologic component [22].  
 
Maternal information was largely incomplete. Over half of the women denied or 
gave no history of having rubella during their pregnancy. This may be due to the 
subclinical nature of the infection or a decreased awareness of rubella symptoms. 
Of the women who reported rubella infection in pregnancy, the majority 
occurred in the first trimester.  
 
Caring for CRS cases is costly in all countries. All cost-benefit studies of rubella 
vaccination, regardless of setting, show that benefits outweigh costs, particularly 
when combined with the measles vaccine (all these studies were conducted in 
countries with coverage >80%) [7]. 
 
In South Africa, mandatory measles vaccination is given at 9 and 18 months of 
age since April 2009 as part of the WHO Expanded Program on Immunization 
(EPI). A combination vaccine against measles, mumps and rubella is available in 
the private sector since 1975. 
 
High measles vaccine coverage presents an opportunity for effective rubella 
vaccination and although the average national coverage with the first measles 
vaccine dose in South Africa is about 88%, there are districts that fall well below 
90% [23]. This requires improvement prior to introducing MMR vaccine. There are 
two approaches for incorporating this into the EPI. The first is selective 
immunization of adolescent girls aiming to protect the population at risk but not 
altering the circulation of the wild type virus. The second is universal vaccination 
of all young children, aiming to eliminate rubella. Inadequate universal 
vaccination may cause an upward shift in the age of rubella infection, thereby 
increasing CRS and is not recommended unless the national program can sustain 
high levels of coverage (>80%) [24]. The choice of approach should be based on 
the level of susceptibility in women of childbearing age, the burden of disease 
due to CRS and the strength of the immunization program as indicated by the 
routine measles coverage. A combined strategy in South Africa may be the most 
effective, immediately eliminating CRS and avoiding a situation similar to the 
Greek tragedy in 1993. An additional benefit would be the inclusion of mumps 




We have documented devastating consequences of CRS. These include severe 
congenital anomalies requiring life-long interventions. Short term consequences 
include prolonged hospitalization, surgical intervention and ICU care. CRS, a 
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